NeuroOne Medical Technologies (NMTC) Competitors $0.83 -0.03 (-3.47%) Closing price 04:00 PM EasternExtended Trading$0.83 +0.00 (+0.48%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NMTC vs. TLSI, ELMD, LNSR, KRMD, PDEX, RCEL, AVR, LAKE, INFU, and BSGMShould you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include TriSalus Life Sciences (TLSI), Electromed (ELMD), LENSAR (LNSR), KORU Medical Systems (KRMD), Pro-Dex (PDEX), Avita Medical (RCEL), Anteris Technologies Global (AVR), Lakeland Industries (LAKE), InfuSystem (INFU), and Biosig Technologies (BSGM). These companies are all part of the "medical equipment" industry. NeuroOne Medical Technologies vs. Its Competitors TriSalus Life Sciences Electromed LENSAR KORU Medical Systems Pro-Dex Avita Medical Anteris Technologies Global Lakeland Industries InfuSystem Biosig Technologies TriSalus Life Sciences (NASDAQ:TLSI) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends. Which has stronger earnings & valuation, TLSI or NMTC? NeuroOne Medical Technologies has lower revenue, but higher earnings than TriSalus Life Sciences. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$35.99M4.08-$30.05M-$1.18-3.29NeuroOne Medical Technologies$3.45M11.99-$12.32M-$0.22-3.77 Which has more volatility & risk, TLSI or NMTC? TriSalus Life Sciences has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Do analysts prefer TLSI or NMTC? TriSalus Life Sciences presently has a consensus price target of $10.75, suggesting a potential upside of 177.06%. NeuroOne Medical Technologies has a consensus price target of $1.45, suggesting a potential upside of 74.70%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TLSI or NMTC more profitable? NeuroOne Medical Technologies has a net margin of -75.41% compared to TriSalus Life Sciences' net margin of -86.61%. TriSalus Life Sciences' return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets TriSalus Life Sciences-86.61% N/A -132.46% NeuroOne Medical Technologies -75.41%-334.64%-124.42% Does the media refer more to TLSI or NMTC? In the previous week, TriSalus Life Sciences and TriSalus Life Sciences both had 9 articles in the media. TriSalus Life Sciences' average media sentiment score of 0.17 beat NeuroOne Medical Technologies' score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NeuroOne Medical Technologies 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in TLSI or NMTC? 2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 27.5% of TriSalus Life Sciences shares are owned by company insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryTriSalus Life Sciences beats NeuroOne Medical Technologies on 9 of the 16 factors compared between the two stocks. Get NeuroOne Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTC vs. The Competition Export to ExcelMetricNeuroOne Medical TechnologiesMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.35M$7.57B$5.58B$9.81BDividend YieldN/A2.72%4.60%4.10%P/E Ratio-3.7771.9030.2825.72Price / Sales11.9926.82388.6180.21Price / CashN/A25.8737.7558.93Price / Book27.6718.428.456.01Net Income-$12.32M$243.10M$3.25B$265.06M7 Day Performance9.21%4.54%4.05%2.80%1 Month Performance14.48%0.47%4.32%1.68%1 Year Performance12.01%18.30%36.25%29.59% NeuroOne Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTCNeuroOne Medical Technologies2.6474 of 5 stars$0.83-3.5%$1.45+74.7%+16.2%$41.35M$3.45M-3.7720News CoverageEarnings ReportGap UpTLSITriSalus Life Sciences3.0212 of 5 stars$4.21+0.2%$10.75+155.3%-30.2%$159.30M$32.14M-3.76106News CoverageEarnings ReportELMDElectromed1.344 of 5 stars$18.61-0.1%$33.50+80.0%+36.6%$156.06M$61.44M24.81160LNSRLENSAR0.6778 of 5 stars$13.04+0.8%$15.00+15.0%+211.2%$153.74M$53.49M-2.69110Earnings ReportKRMDKORU Medical Systems1.938 of 5 stars$3.28-3.0%$4.63+41.0%+81.4%$151.34M$33.65M-29.8280Positive NewsPDEXPro-Dex3.2558 of 5 stars$45.09-1.4%$56.00+24.2%+127.0%$146.99M$53.84M16.10140Positive NewsRCELAvita Medical1.463 of 5 stars$5.28-1.3%$16.50+212.5%-40.1%$139.55M$64.25M-2.41130News CoverageEarnings ReportAnalyst ForecastAVRAnteris Technologies GlobalN/A$3.80+10.8%$16.50+334.2%N/A$137.04M$2.49M0.00138News CoverageEarnings ReportGap UpLAKELakeland Industries4.7847 of 5 stars$14.09+2.4%$26.00+84.5%-35.0%$134.07M$177.65M-4.682,100INFUInfuSystem3.5721 of 5 stars$6.07+3.8%$12.50+105.9%N/A$127.57M$137.58M101.18410BSGMBiosig Technologies2.3732 of 5 stars$4.02-9.3%$10.00+148.8%+784.6%$109.75M$40K0.0050News Coverage Related Companies and Tools Related Companies TLSI Competitors ELMD Competitors LNSR Competitors KRMD Competitors PDEX Competitors RCEL Competitors AVR Competitors LAKE Competitors INFU Competitors BSGM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTC) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access